Enkephalinase enzyme inhibiting compounds
US4329495A · kind A · utility
12Cited by
1References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 18, 1981 |
| Grant date | May 11, 1982 |
| Priority date | — |
| Expiry date | May 18, 2001 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07C327/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Chiral 2-(2-benzyl-3-mercaptopropionylamino)-1-alkanol derivatives and chiral 2-(2-benzyl-3-mercaptopropionylamino)-4-methylthiobutyric acids are inhibitors of enkephalinase enzyme, reflecting their clinical utility as analgesics or anticonvulsant agents, or as therapy for disorders in which endogenous enkephalin levels are below normal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.